205 related articles for article (PubMed ID: 9785202)
1. Neuroprotective agents in acute ischemic stroke.
Hock NH
J Cardiovasc Nurs; 1998 Oct; 13(1):17-25. PubMed ID: 9785202
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis and Acute Brain Ischemia in Ischemic Stroke.
Radak D; Katsiki N; Resanovic I; Jovanovic A; Sudar-Milovanovic E; Zafirovic S; Mousad SA; Isenovic ER
Curr Vasc Pharmacol; 2017; 15(2):115-122. PubMed ID: 27823556
[TBL] [Abstract][Full Text] [Related]
3. [Thrombolytics and neuroprotective agents in the treatment of the patient with an acute cerebrovascular ischemic accident].
Yepes MS
Rev Neurol; 2001 Feb 1-15; 32(3):259-66. PubMed ID: 11310282
[TBL] [Abstract][Full Text] [Related]
4. The only evidence based neuroprotective therapy for acute ischemic stroke: thrombolysis.
Köhrmann M; Schellinger PD; Schwab S
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):563-71. PubMed ID: 21619867
[TBL] [Abstract][Full Text] [Related]
5. Rationale for early intervention in acute stroke.
Albers GW
Am J Cardiol; 1997 Aug; 80(4C):4D-10D; discussion 35D-39D. PubMed ID: 9284038
[TBL] [Abstract][Full Text] [Related]
6. Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications.
Baron JC
Cerebrovasc Dis; 2001; 11 Suppl 1():2-8. PubMed ID: 11244194
[TBL] [Abstract][Full Text] [Related]
7. [Current state on development of neuroprotective agents for cerebral ischemia].
Hirouchi M; Ukai Y
Nihon Yakurigaku Zasshi; 2002 Aug; 120(2):107-13. PubMed ID: 12187623
[TBL] [Abstract][Full Text] [Related]
8. Adventures in the pathophysiology of brain ischemia: penumbra, gene expression, neuroprotection: the 2002 Thomas Willis Lecture.
Ginsberg MD
Stroke; 2003 Jan; 34(1):214-23. PubMed ID: 12511777
[TBL] [Abstract][Full Text] [Related]
9. [The objective of acute stroke therapy and neuroprotective therapeutic approaches].
Fisher M
Rev Neurol; 1999 Sep 16-30; 29(6):536-44. PubMed ID: 10584269
[TBL] [Abstract][Full Text] [Related]
10. Deterioration in acute ischemic stroke as the target for neuroprotection.
Serena J; Rodríguez-Yáñez M; Castellanos M
Cerebrovasc Dis; 2006; 21 Suppl 2():80-8. PubMed ID: 16651818
[TBL] [Abstract][Full Text] [Related]
11. Phase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research.
Reis C; Akyol O; Ho WM; Araujo C; Huang L; Applegate R; Zhang JH
Biomed Res Int; 2017; 2017():4863079. PubMed ID: 28286764
[TBL] [Abstract][Full Text] [Related]
12. Pre- and postischemic effects of the NMDA receptor antagonist dizocilpine maleate (MK-801) on collateral cerebral blood flow.
Robertson SC; Wetjen NM; Beer BJ; Loftus CM
J Neurosurg; 1997 Dec; 87(6):927-33. PubMed ID: 9384406
[TBL] [Abstract][Full Text] [Related]
13. Is it time to definitely abandon neuroprotection in acute ischemic stroke?
Sacchetti ML
Stroke; 2008 Jun; 39(6):1659-60. PubMed ID: 18369169
[No Abstract] [Full Text] [Related]
14. Intranasal Delivery of Apelin-13 Is Neuroprotective and Promotes Angiogenesis After Ischemic Stroke in Mice.
Chen D; Lee J; Gu X; Wei L; Yu SP
ASN Neuro; 2015; 7(5):. PubMed ID: 26391329
[TBL] [Abstract][Full Text] [Related]
15. Targeting the brain: neuroprotection and neurorestoration in ischemic stroke.
Saver JL
Pharmacotherapy; 2010 Jul; 30(7 Pt 2):62S-9S. PubMed ID: 20575624
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection targeting ischemic penumbra and beyond for the treatment of ischemic stroke.
Liu R; Yuan H; Yuan F; Yang SH
Neurol Res; 2012 May; 34(4):331-7. PubMed ID: 22643076
[TBL] [Abstract][Full Text] [Related]
17. Evolving therapeutic approaches to treating acute ischemic stroke.
Weinberger JM
J Neurol Sci; 2006 Nov; 249(2):101-9. PubMed ID: 17005205
[TBL] [Abstract][Full Text] [Related]
18. YM872, a highly water-soluble AMPA receptor antagonist, preserves the hemodynamic penumbra and reduces brain injury after permanent focal ischemia in rats.
Shimizu-Sasamata M; Kano T; Rogowska J; Wolf GL; Moskowitz MA; Lo EH
Stroke; 1998 Oct; 29(10):2141-8. PubMed ID: 9756596
[TBL] [Abstract][Full Text] [Related]
19. [Advances in the diagnosis and treatment of cerebral ischemia during the acute phase].
Katayama Y; Igarashi H
Rinsho Shinkeigaku; 2003 Nov; 43(11):887-90. PubMed ID: 15152494
[TBL] [Abstract][Full Text] [Related]
20. The role of diffusion- and perfusion-weighted magnetic resonance imaging in drug development for ischemic stroke: from laboratory to clinics.
Tatlisumak T; Strbian D; Abo Ramadan U; Li F
Curr Vasc Pharmacol; 2004 Oct; 2(4):343-55. PubMed ID: 15320814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
